Matsumoto Oil and Fat Pharmaceuticals plans to implement executive changes on June 25, 2026. The new candidate for Audit & Supervisory Board Member is Mr. Shinichiro Yamane, while Mr. Shuhei Kuge is scheduled to resign. These changes are expected to be officially approved at the General Meeting of Shareholders and the Board of Directors following the meeting.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4365","jir_company_name":"Matsumoto Oil and Fat Pharmaceuticals Co., Ltd.","jir_importance":"\u2605\u2606\u2606\u2606\u2606","jir_publication_date":"2026-05-18","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4365-20260518-01.pdf","jir_short_summary":"Matsumoto Oil and Fat Pharmaceuticals plans to implement executive changes on June 25, 2026. The new candidate for Audit & Supervisory Board Member is Mr. Shinichiro Yamane, while Mr. Shuhei Kuge is scheduled to resign. These changes are expected to be officially approved at the General Meeting of Shareholders and the Board of Directors following the meeting.","jir_summary":"### Overview of Executive Changes\nMatsumoto Oil and Fat Pharmaceuticals plans to implement executive changes effective June 25, 2026. The candidate for new Audit & Supervisory Board Member is Mr. Shinichiro Yamane, who is scheduled to be appointed as Full-time Auditor, and Mr. Shuhei Kuge is scheduled to resign from his position. These changes are expected to be formally approved at the Annual General Meeting of Shareholders held on June 25, 2026, and at the subsequent meeting of the Board of Directors.\n\n### Impact of Executive Changes and Future Outlook\nThe purpose of these executive changes is to strengthen the corporate governance structure, which is expected to contribute to the stability of management from the perspective of shareholders and investors. After formal approval, new developments in management policies and business strategies are anticipated; however, the specific impact on business operations remains currently unknown.","jir_financial_highlights":"","jir_category":"","jir_hashtags":"#MatsumotoOilFatPharmaceuticals, #ExecutiveChanges, #JapanEquity","jir_key_figures":"Scheduled date of executive change: June 25, 2026\nNew candidate for Audit & Supervisory Board Member: Mr. Shinichiro Yamane\nScheduled resignation of Audit & Supervisory Board Member: Mr. Shuhei Kuge","jir_meta_title":"\u3010Matsumoto Oil and Fat Pharmaceuticals\u3011Notice of Executive Changes\uff5cJune 25, 2026","jir_meta_description":"Matsumoto Oil and Fat Pharmaceuticals plans to implement executive changes on June 25, 2026. The new candidate for Audit & Supervisory Board Member is Mr. Shinichiro Yamane, and the scheduled resigning member is Mr. Shuhei Kuge. Formal approval will be sought after the shareholders' meeting.","jir_og_title":"\u3010Matsumoto Oil and Fat Pharmaceuticals\u3011Notice of Executive Changes\uff5cJune 25, 2026","jir_og_description":"Announcement of planned executive changes at Matsumoto Oil and Fat Pharmaceuticals. Information on new and departing executives and the company's governance outlook.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16710,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-52728","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n